Amplifon stock gains on resilient revenue and margin base
Published on 07/18/2026 at 09:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amplifon (IT0004056880) stock is best read through its latest published operating base, which showed revenue of EUR 2.26 billion in fiscal 2024, up 6.6% year on year, with EBITDA of EUR 554.3 million and an EBITDA margin of 24.5%. The company also reported net profit of EUR 152.0 million for fiscal 2024, while the balance sheet closed the year with net debt of EUR 1.08 billion.
EUR 2.26 billion revenue
The fiscal 2024 top line of EUR 2.26 billion gives Amplifon a large installed base in hearing care, and the 6.6% increase from fiscal 2023 is the cleanest comparison point in the available data. EBITDA of EUR 554.3 million and a 24.5% margin show that earnings quality remained tied to scale rather than one-off items.
For investors, the margin matters as much as the revenue line because the business has to convert service demand into cash while financing a capital structure that still carried EUR 1.08 billion of net debt at year-end 2024.
Margin and debt
Amplifon’s latest annual report shows that the company finished fiscal 2024 with net profit of EUR 152.0 million, which gives a second anchor for the earnings base beyond EBITDA. A revenue gain of 6.6% alongside a 24.5% margin indicates that growth and profitability were moving in the same direction, even before any newer quarterly update is considered.
The company’s investor relations page remains the natural source for the next update cycle, and Amplifon stock will likely keep trading against the same two questions: how fast sales grow, and how much of that growth stays above the line.
Hearings and services
Amplifon’s product logic is straightforward: hearing solutions are sold through a service-heavy retail model that depends on repeat customer contact, fitting expertise, and after-sales support. That makes reported margin and debt more important than pure unit growth, because every store visit can lift revenue only if the operating structure remains disciplined.
Stock level and context
A dated market quote was not available in the source set for this call, so the current stock view has to be anchored to the latest verified financial metrics instead. On that basis, Amplifon stock is defined more by the fiscal 2024 base of EUR 2.26 billion revenue, EUR 554.3 million EBITDA, and EUR 152.0 million net profit than by any unverified intraday move.
Amplifon fiscal 2024 numbers
The latest annual figures give the cleanest evidence set for revenue, EBITDA, margin, profit, and debt.
Hearing care model
The representative product line is hearing solutions, but the investment case here is not a gadget story. It is a service model with a fiscal 2024 revenue base of EUR 2.26 billion, EBITDA of EUR 554.3 million, and net debt of EUR 1.08 billion, all of which help frame operating leverage.
Amplifon stock base
Amplifon stock is quoted on Borsa Italiana in Milan, with the company identified by ISIN IT0004056880. The latest verified financial snapshot in this article comes from fiscal 2024, not from a fresh market quote, and it shows revenue up 6.6% to EUR 2.26 billion, EBITDA at EUR 554.3 million, and net profit at EUR 152.0 million.
Amplifon company facts
- Company: Amplifon S.p.A.
- ISIN: IT0004056880
- Ticker: BIT: AMP
- Trading venue: Borsa Italiana
- Sector / Industry: Health Care / Health Care Equipment & Supplies
- Index membership: FTSE MIB
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
